Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
Docetaxel is a commonly used taxane chemotherapeutic agent in the treatment of a variety of cancers, including breast cancer, ovarian cancer, prostate cancer, non-small cell lung cancer, gastric cancer, and head and neck cancer. Docetaxel exerts its anti-cancer effects through inhibition of the cell...
Saved in:
| Main Authors: | Aleymi M. Perez, Nicole I. Haberland, Mariya Miteva, Tongyu C. Wikramanayake |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/31/9/423 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minoxidil oral en dosis bajas en alopecia frontal fibrosante: serie de 122 pacientes
by: C. Pindado-Ortega, et al.
Published: (2025-04-01) -
Male androgenetic alopecia
by: Gabriel Lazzeri Cortez, et al.
Published: (2025-04-01) -
EXPERIENCE OF SCALP COOLING FOR PREVENTION CHEMOTHERAPY-INDUCED HAIR LOSS
by: I. S. Polezhaeva, et al.
Published: (2017-06-01) -
Research of domestic market medicinal agents based on Minoxidil and it’s derivatives that are used in treatments for Alopecia
by: Zhamali Karim, et al.
Published: (2019-12-01) -
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
by: Portia Lagmay-Fuentes, et al.
Published: (2024-07-01)